Open AccessThe AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
Author(s) -
Fatma Şanli,
Neslişah Barlak,
Ahsen Kilinç,
Özel Çapik,
Abdülmelik Aytatli,
Ömer Faruk Karataş
Publication year - 2020
Publication title -
the european research journal
Language(s) - English
Resource type - Journals
ISSN - 2149-3189
DOI - 10.18621/eurj.624088
Subject(s) - medicine , protein kinase b , cancer research , apoptosis , pi3k/akt/mtor pathway , annexin , cancer , clonogenic assay , context (archaeology) , cancer cell , viability assay , immunology , flow cytometry , biology , biochemistry , paleontology